schizandrin b has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, T; Jin, H; Ma, M; Song, A; Wei, N; Yang, J; Zheng, S | 1 |
| Cao, MF; Chen, F; Gao, YP; Qian, KX; Wang, T; Wu, YF; Zumbika, EP | 1 |
2 other study(ies) available for schizandrin b and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Schisandrin B induces HepG2 cells pyroptosis by activating NK cells mediated anti-tumor immunity.
Topics: Carcinoma, Hepatocellular; Caspase 3; Hep G2 Cells; Humans; Killer Cells, Natural; Lignans; Liver Neoplasms; Pyroptosis | 2023 |
Down-modulation of heat shock protein 70 and up-modulation of Caspase-3 during schisandrin B-induced apoptosis in human hepatoma SMMC-7721 cells.
Topics: Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Caspases; Cell Differentiation; Cell Proliferation; Cyclooctanes; Down-Regulation; Flow Cytometry; HSP70 Heat-Shock Proteins; Humans; Lignans; Liver Neoplasms; Polycyclic Compounds; Tumor Cells, Cultured; Up-Regulation | 2004 |